LUMEXA IMAGING HOLDINGS INC (LMRI)
Health Care · diagnostic imaging centers · NASDAQ
Lumexa Imaging Holdings is a diagnostic imaging services provider leveraging a network of consolidated and affiliated centers.
What LUMEXA IMAGING HOLDINGS INC does
Lumexa Imaging Holdings, Inc. is a provider of diagnostic imaging services. The company generates revenue primarily through net patient service revenue and management fees, operating in part through consolidated variable interest entities (VIEs) and unconsolidated affiliates.
Themes: diagnostic imaging, healthcare services, outpatient care
Fundamentals
- Price$10.89 as of 2026-10-22 close
- Market cap$1.0B as of 2026-08-12 (share count; price 2026-10-22)
- P/En/a earnings data not available
- ROICn/a No figure: its 10-K tags no operating income.
- Debt / equity1.36 borrowings, leases excluded / equity — 10-Q/10-K balance sheet 2026-06-30
- Beta1.82 as of 2026-09-03
- Last reported earnings2026-08-12 SEC EDGAR Form 8-K (Item 2.02)
Quarterly results
Balance sheet at 2026-06-30
- Cash and equivalents$70M
- Total debt$834M borrowings only; leases excluded
- Net debt$764M total debt − cash − short-term investments
From the company's own SEC 10-Q and 10-K filings (XBRL), re-read every week. Figures in US dollars as filed; informational only — not financial advice.
How LUMEXA IMAGING HOLDINGS INC looks technically
LUMEXA IMAGING HOLDINGS INC (LMRI) is trading 7.3% below its 200-day average, the long-term trend line — a long-term downtrend. Its 50-day average has held below its 200-day average for at least 8 trading days — a long-sustained "death cross", a bearish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30). It just made a new 20-day high, its first since 2026-09-18, pushing above its recent trading range. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 5% of the past ~6 months), which often precedes a bigger move.
Trend
8
| Distance from the 200-day | it is trading 7.3% below its 200-day average, the long-term trend line — a long-term downtrend | -7.3% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $11.14 | $11.14 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $11.75 | $11.75 |
| Swing structure | each recent peak has been lower than the one before it and each dip deeper — the pattern chart-watchers call a downtrend, which describes where price has already been and not where it goes next | lower highs and lower lows |
| Last swing turn | its last significant turn was a swing high 16 calendar days ago — the swings before that are what the structure reading is measured on | 16 sessions |
| Wave structure | its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five; the labelling fails if price closes above 11.08. It is the only labelling that fits, though not with textbook proportions, and it describes the swings already printed, not what comes next. | possible downward five-wave sequence, in wave 5 (atypical proportions) |
| Since the 50/200 cross | its 50-day average has held below its 200-day average for at least 8 trading days — a long-sustained "death cross", a bearish long-term signal | at least 8 sessions |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 17, below the 25 that marks a real trend) | 16.5 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 53, neither overbought (above 70) nor oversold (below 30) | 53.4 |
|---|---|---|
| Position in its 14-day range | it is trading in the upper half of its 14-day range ($10.10 to $11.12) — its "stochastic" reading is 77 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been climbing within that range over the last few sessions. | 77.5 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, is in positive territory (momentum leaning bullish) | 13 sessions |
Range
7
| Since a 20-day breakout | it just made a new 20-day high, its first since 2026-09-18, pushing above its recent trading range | 1 session |
|---|---|---|
| Since a 55-day breakout | it made a new 55-day low about 21 trading days ago | 21 sessions |
| All-time high | its highest closing price on record is $19.45 (set on 2025-12-15) | $19.45 |
| Given back of the 52-week move | not available for this company yet | n/a |
| Nearest price level | not enough price history yet — needs 252 trading sessions | n/a |
| All-time low | its lowest closing price on record is $6.45 (set on 2026-05-15) | $6.45 |
| Above the all-time low | it is 68.8% above its all-time low | +68.8% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 5% of the past ~6 months), which often precedes a bigger move | 5th percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $0.4608 between its high and its low — about 4.2% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $0.4608 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $10.05 and $11.02 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $10.05 – $10.54 – $11.02 |
| Typical daily range (% of price) | its price moves about 4.2% in a typical session — about typical for the companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 4.2% |
| Stretch from the 200-day average | it is trading 1.9 daily ranges below its 200-day average price (7.3% below it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.9 daily ranges below its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is about normal versus its 30-day average | 0.78× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating is unchanged since the prior reading | unchanged |
Candlestick patterns
3
| Since a doji | 4 sessions ago it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | 4 sessions ago |
|---|---|---|
| Since a hammer | 8 sessions ago, after a stretch of decline, it sold off hard during the session and then closed back near its high — a "hammer", the long lower wick showing the drop was bought back before the close | 8 sessions ago |
| Since a bullish engulfing | 1 session ago it opened below the previous session's close and finished above that session's open — a "bullish engulfing" pair, where one up day more than undid the down day before it | 1 session ago |
Price gaps
2
| Gap at the open | it opened on 2026-10-22 0.7% below the previous session's close — an overnight gap, the part of the move that happened while the market was shut, and traded back through that level before the close | -0.7% |
|---|---|---|
| Gap filled | a 2.8% gap up opened on 2026-10-05 has been "filled" 10 sessions ago — price traded back through the level the gap left behind, and it took 3 sessions to close | 10 sessions ago |
Price streaks
1
| Closing streak | it has closed higher 2 sessions in a row, a +1.97% move over the run — an unbroken run of up days, which describes what has already happened and says nothing about the next session | 2 sessions up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 4.7 percentage points (the stock gained 3.5% while the market lost 1.2%) | +4.7% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock has tracked the market almost exactly (the stock gained 2.3% while the market gained 2.2%) | +0.0% |
| vs market, 6 months | over the past 6 months this stock beat the market by 9.3 percentage points (the stock gained 16.7% while the market gained 7.4%) | +9.3% |
| vs market, 12 months | not available for this company yet | n/a |
Signal agreement
2
| Bullish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bullish state: a fresh 20-day high, MACD momentum is positive, outperforming the market over 6 months — these describe past price behaviour, not a forecast | 3 of 9 |
|---|---|---|
| Bearish technical signals | 3 of the 9 technical signals we can compute for it are currently in a bearish state: a "death cross" — its 50-day average is below its 200-day, trading below its 200-day average, trading below the Ichimoku cloud — these describe past price behaviour, not a forecast | 3 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 4.7% below the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-09-16 and projected forward over today's price, the side traders read as an established downtrend, with the band above acting as the level that would have to be cleared. The band itself is moderate, spanning 4.2% of the share price. | -4.7% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 2% below the average price paid so far this year, so the typical buyer over that stretch is under water. That average is $11.08 — a volume-weighted average of daily closes over 193 sessions, not a true tick-by-tick VWAP. | -1.7% |
|---|---|---|
| Vs the average paid since it last reported | the price is 3% below the average price paid since it last reported on 2026-08-12 (its 8-K), so the typical buyer over that stretch is under water. That average is $11.18 — a volume-weighted average of daily closes over 51 sessions, not a true tick-by-tick VWAP. | -2.6% |
Wave structure
Its recent swings can be read as a five-part downward sequence — what Elliott-wave chartists call an impulse — now in leg 5 of five.
This labelling fails — stops being a possible reading at all — if it closes above $11.08.
It is the only labelling that fits these swings, though its proportions are not the textbook ones. It was chosen from 3 labellings that survived the rules, counting shorter readings of the same bars.
On past moves of this shape the leg has usually ended somewhere between $8.00 and $9.90 — that is where it has tended to end if the count holds, not a forecast of where the price goes.
This reading has stood for 8 trading days, since 2026-10-13.
Read from daily closes as of 2026-10-22.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading below the 200-day moving average · Trading below the 50-day moving average · Broke out to a new 20-day high · in a Bollinger Band volatility squeeze · trendless / choppy (low ADX) · Under water since its last earnings report (below the anchored VWAP) | Learn: moving average · golden cross · adx · rsi · breakout · bollinger bands
Based on daily closing prices as of 2026-10-22. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingStrong Buy (1.20 mean, 1=Strong Buy…5=Strong Sell) — 9 analysts
- Mean price target$17.67 range $13.00 – $23.00; median $18.00
Analyst estimates, as of 2026-10-17. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for LMRI
- Consensus EPS estimate$0.182 next reporting period, as of 2026-10-17
- Estimate change, 30 days-$0.00398 (-2.1%) from $0.1859, on 2026-09-12, 35-day window
- Readings revised upward0% of 8 comparable readings
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["High levels of long-term debt relative to equity","Reliance on management fee arrangements and unconsolidated affiliates for earnings contribution","Exposure to regulatory and reimbursement risks inherent in the diagnostic imaging sector"]
What changed in the latest 10-Q
AI-assisted comparison of LMRI's 10-Q filed 2026-08-13 against the prior one filed 2026-05-12.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-08-13) updates the as-of date in the Overview to June 30, 2026, with 192 centers in 14 states and nine joint venture partnerships with health systems.
- Newer filing (2026-08-13) reports consolidated net patient service revenue of $203,735 for the three months ended June 30, 2026, and $198,185 for the three months ended June 30, 2025.
- Newer filing (2026-08-13) reports consolidated net patient service revenue of $401,053 for the six months ended June 30, 2026, and $390,483 for the six months ended June 30, 2025.
- Newer filing (2026-08-13) reports consolidated and system-wide payor mix tables for three- and six-month periods ended June 30, 2026 and 2025.
- Newer filing (2026-08-13) reports consolidated and system-wide MRI and CT percentage tables for three- and six-month periods ended June 30, 2026 and 2025.
- Removed:
- Older filing (2026-05-12) reports consolidated net patient service revenue of $197,318 for the three months ended March 31, 2026, and $192,298 for the three months ended March 31, 2025.
- Older filing (2026-05-12) includes narrative sentences describing MRI and CT volume/revenue percentages for the three months ended March 31, 2026 and 2025.
- Older filing (2026-05-12) includes narrative sentences describing commercial, government, and self-pay/liens/other payor percentages for consolidated and system-wide revenue for the three months ended March 31, 2026 and 2025.
- Reworded:
- Newer filing (2026-08-13) changed the Overview as-of date and center count from March 31, 2026 (189 centers in 13 states, eight joint venture partnerships) to June 30, 2026 (192 centers in 14 states, nine joint venture partnerships).
- Newer filing (2026-08-13) changed the consolidation comparison from March 31, 2026 vs March 31, 2025 (103 of 189 consolidated, 86 equity method vs 99 of 182 consolidated, 83 equity method) to June 30, 2026 vs June 30, 2025 (104 of 192 consolidated, 88 equity method vs 99 of 184 consolidated, 85 equity method).
- Newer filing (2026-08-13) replaced narrative payor-mix text with tables presenting commercial, government, and self-pay/liens/other percentages for consolidated and system-wide revenue for the three- and six-month periods ended June 30, 2026 and 2025.
- Newer filing (2026-08-13) replaced narrative MRI/CT percentage text with tables presenting consolidated and system-wide MRI and CT percentages of revenues and volumes for the three- and six-month periods ended June 30, 2026 and 2025.
- Center roll-forward table updated: newer filing (2026-08-13) adds 2 de novos and 2 acquisitions and no closed/sold centers from December 31, 2025 to June 30, 2026 (104 consolidated, 88 JV, 192 total); older filing (2026-05-12) adds 1 de novo and no acquisitions/closed from December 31, 2025 to March 31, 2026 (103 consolidated, 86 JV, 189 total).
- Notes:
- The newer filing excerpt is truncated at the end of the 'Favorable and Sustainable Reimbursement' section, so later portions of the MD&A are not available for comparison.
- The older filing excerpt is truncated at 'We are broadly diversified across over 600 payor contracts...' so later portions of the MD&A are not available for comparison.
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
No open-market insider purchases or sales recorded in the last 90 days, of which we have read Form 4 filings through 2026-10-17. The 6 days since 2026-10-17 have not been checked yet.
- Last 180 days · read to 2026-10-172 buys ($476863) · 0 sells — 2 buying insiders
Most recent open-market transaction: 2026-05-19. Based on Form 4 filings read through 2026-10-17; anything filed since is not yet included.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about LMRI's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Institutional ownership (13F)
4 institutional 13F filers reported holding LMRI as of 2026-06-30 (quarter-end position, filed within 45 days).
- Distinct 13F filers 4
- Reported shares held 2,117,685
- Reported value $23,887,486
reported quarterly holdings change (2026-03-31 → 2026-06-30): 0 new, 1 increased, 3 decreased, 1 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Ask about LMRI's institutional holders → See what each manager we track holds →
Short interest (FINRA)
LMRI had 2,023,071 shares of reported short interest as of the 2026-09-30 FINRA settlement date (delayed, bi-monthly; not real-time).
LMRI had 2.11% of its shares outstanding sold short as of the 2026-09-30 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 4.12 days to cover at the same settlement.
- Reported short interest (shares) 2,023,071
- Short interest (% of shares outstanding) 2.11%
- Prior settlement (shares) 2,126,195
- Reported change -4.85%
- Days to cover (reported) 4.12
Reported to FINRA as of the 2026-09-30 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- RadNet (RDNT)
- Envision Healthcare
- U.S. Radiology Specialists
- Alliance HealthCare Services
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare LMRI vs…
LUMEXA IMAGING HOLDINGS INC is found in…
Frequently asked questions
What does LUMEXA IMAGING HOLDINGS INC (LMRI) do?
Lumexa Imaging Holdings, Inc. is a provider of diagnostic imaging services. The company generates revenue primarily through net patient service revenue and management fees, operating in part through consolidated variable interest entities (VIEs) and unconsolidated affiliates.
What sector is LUMEXA IMAGING HOLDINGS INC (LMRI) in?
LUMEXA IMAGING HOLDINGS INC (LMRI) is classified in the Health Care sector. Its industry is diagnostic imaging centers. It trades on NASDAQ.
Who are LUMEXA IMAGING HOLDINGS INC's (LMRI) competitors?
Notable peers of LUMEXA IMAGING HOLDINGS INC (LMRI) include RadNet, Envision Healthcare, U.S. Radiology Specialists and Alliance HealthCare Services. This peer set is informational only — not financial advice.
Is LUMEXA IMAGING HOLDINGS INC (LMRI) overbought or oversold right now?
LUMEXA IMAGING HOLDINGS INC (LMRI) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 53, in the neutral middle (as of 2026-10-22). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on LMRI come from?
Fundamentals come from SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest; prices are market data, as of 2026-09-03; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.